Avanos Medical (AVNS) Non-Current Assets (2013 - 2026)
Avanos Medical (AVNS) posted Non-Current Assets of $725.1 million for Q1 2026, up 0.95% sequentially from $718.3 million in Q4 2025, and down 4.01% YoY from $755.4 million in Q1 2025.
Avanos Medical (AVNS) Non-Current Assets (2013 - 2026) Analysis & Trends
Avanos Medical has reported Non-Current Assets for 14 years, with the latest figure at $725.1 million in Q1 2026.
- Quarterly Non-Current Assets fell 4.01% year-over-year to $725.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 billion (down 26.8% YoY) and the FY2025 annual result came in at $718.3 million, down 5.59% from the prior year.
- Non-Current Assets climbed to $725.1 million in Q1 2026 per AVNS's latest filing, from $718.3 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $1.3 billion in Q1 2022 and troughed at $683.0 million in Q2 2025.
- A 5-year average of $1.1 billion and a median of $1.2 billion in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets advanced 10.53% in 2022, then plunged 42.3% in 2025.
- Over 5 years, Non-Current Assets stood at $1.2 billion in 2022, then increased by 3.66% to $1.2 billion in 2023, then plunged by 36.88% to $760.8 million in 2024, then slipped by 5.59% to $718.3 million in 2025, then rose by 0.95% to $725.1 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $725.1 million, $718.3 million, and $716.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 725.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 725.10 Mn |
| Dec 31, 2025 | 718.30 Mn |
| Sep 30, 2025 | 716.30 Mn |
| Jun 30, 2025 | 683.00 Mn |
| Mar 31, 2025 | 755.40 Mn |
| Dec 31, 2024 | 760.80 Mn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 1.18 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 1.21 Bn |
| Sep 30, 2023 | 1.20 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Mar 31, 2023 | 1.28 Bn |
| Dec 31, 2022 | 1.16 Bn |
| Sep 30, 2022 | 1.31 Bn |
| Jun 30, 2022 | 1.32 Bn |
| Mar 31, 2022 | 1.33 Bn |
| Dec 31, 2021 | 1.18 Bn |
| Sep 30, 2021 | 1.19 Bn |
| Jun 30, 2021 | 1.24 Bn |